BIHC >=98% (HPLC)

BIHC >=98% (HPLC) Chemische Eigenschaften,Einsatz,Produktion Methoden

• Verwenden

  BIHC is a Her2-CD3 bispecific antibody constructed from a single-domain antibody targeting Her2 and a single-chain variable fragment (Fv) targeting CD3, formatted in an IgG-like structure. BIHC demonstrates effective antitumor activity in vivo, specifically binding to tumor cells expressing Her2 and efficiently eliminating Her2-positive cancer cells by recruiting T cells, thus being used in the study of Her2-positive cancers[1].

• Einzelnachweise

  [1] Xing J, et al. BiHC, a T-Cell-Engaging Bispecific Recombinant Antibody, Has Potent Cytotoxic Activity Against Her2 Tumor Cells. Transl Oncol. 2017 Oct;10(5):780-785. DOI:10.1016/j.tranon.2017.07.003

BIHC >=98% (HPLC) Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global(1)Suppliers